Drug intelligence / Profile preview

Osteo Pharm

Development stage
Phase 4
Lead developer
Pharma Chemie
Modality
Small Molecules
Administration
Oral
01

Overview

Osteo Pharm is an oral fixed-dose combination dietary supplement and therapeutic agent developed and manufactured by Pharma Chemie. It is formulated as a tablet containing 500 mg of calcium carbonate and 400 IU of vitamin D3 (cholecalciferol). Osteo Pharm is primarily indicated for the prevention and treatment of calcium and vitamin D deficiencies, as well as the management of associated bone disorders such as osteoporosis, osteomalacia, rickets, and hypoparathyroidism. Calcium carbonate provides elemental calcium to support bone mineralization and density, acting as an agonist at the extracellular calcium-sensing receptor (CASR). Cholecalciferol is metabolized in vivo to its active form, calcitriol, which binds to the intracellular vitamin D receptor (VDR) to enhance intestinal calcium absorption and maintain systemic calcium homeostasis.

Brand names
Osteo Pharm
Other names
Osteo Pharm Tabletcalcium carbonate + cholecalciferolcalcium carbonate + vitamin D3
02

Targets

CaSR (Extracellular calcium-sensing receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Osteo Pharm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osteo Pharm.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call